SGP SpyGlass Pharma, Inc. Common Stock
$25.39
▲ 1.34%
44
Value
50
P/E—
—
P/B—
—
P/S—
—
EV/EBITDA—
—
Growth
50
Revenue Growth—
—
EPS Growth—
—
FCF Growth—
—
Momentum
55
12-Month Return—
—
3-Month Return—
—
1-Month Return14.3%
79
RSI (14)53.51
57
50/200 MABearish
30
Profitability
50
ROE—
—
ROA—
—
Gross Margin—
—
Operating Margin—
—
Net Margin—
—
FCF Yield—
—
Risk
16
Beta0.00
35
60-Day Volatility65.0%
0
QScore Analysis